ArticleFrontiers in oncology2026

Case Report: Neoadjuvant chemoimmunotherapy achieving pathological complete response in two cases of stage III EGFR-mutant NSCLC with high PD-L1 expression.

Diming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.